SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-002563
Filing Date
2022-02-04
Accepted
2022-02-04 20:19:06
Documents
2
Period of Report
2022-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1757
2 POWER OF ATTORNEY poa_newcomer.htm EX-24.1 7209
  Complete submission text file 0001567619-22-002563.txt   10478
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 264 BUSHAWAY ROAD WAYZATA MN 55391-1901
Business Address
Newcomer Lee Nisley (Reporting) CIK: 0001788981 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36721 | Film No.: 22595230